With the analysis among 368 patents, we discovered top 133 key players by total patent application. Acerta Pharma BV, Bristol Myers Squibb Co., CytomX Therapeutics, Inc. are dominant in this area. They take 11.96% of the total patent filing.
Noord-Brabant, Netherlands
Patent: 14
New York, United States
Patent: 12
CytomX Therapeutics, Inc.
California, United States
Patent: 11
The General Hospital Corp.
Massachusetts, United States
Patent: 11
California, United States
Patent: 11
Ohio State Innovation Foundation
Ohio, United States
Patent: 9
Great Novel Therapeutics Biotech & Medicals Corp.
Taiwan Province, China
Patent: 8
New York, United States
Patent: 8
Rubicon Biotechnology LLC
California, United States
Patent: 8
Massachusetts, United States
Patent: 7
With the analysis among 28 patents, we discovered top 8 start-ups by total patent application. Hibercell, Inc., Institut National de la Santé et de la Recherche Médicale, Eliaz Therapeutics, Inc. are active in this area.
New York, United States
Patent: 8
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 4
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 3
Noord-Brabant, Netherlands
Patent: 2
Kalivir Immunotherapeutics
Pennsylvania, United States
Patent: 1
Beijing Chineo Medical Technology Co., Ltd
With the analysis among related 317 patents applied in the last 5 years. We discover 195 most active companies in this area. The fast-growing The General Hospital Corp., Great Novel Therapeutics Biotech & Medicals Corp., China Pharmaceutical University take 7.26% of patent filing during this period.
The General Hospital Corp.
Massachusetts, United States
Patent: 9
Great Novel Therapeutics Biotech & Medicals Corp.
Taiwan Province, China
Patent: 8
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
Nanjing Songyue Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 5
Shanghai Shi, China
Patent: 4
New York, United States
Patent: 4
Jiangsu Sheng, China
Patent: 4
Zhejiang Sheng, China
Patent: 4
With the analysis among related 317 patents in last 5 years, we discover 144 new entrants. Great Novel Therapeutics Biotech & Medicals Corp., Nanjing Songyue Biotechnology Co., Ltd., NantBio Inc are the most active new entrants in this area.
Great Novel Therapeutics Biotech & Medicals Corp.
Taiwan Province, China
Patent: 8
Nanjing Songyue Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 4
Lyvgen Biopharma Co., Ltd
Shanghai Shi, China
Patent: 3
California, United States
Patent: 3
The University of Western Australia
Tasmania, Australia
Patent: 3
East China Normal University
Shanghai Shi, China
Patent: 3
OncoPlex Diagnostics, Inc.
With the analysis among 385 patents, we discovered top 95 universities and scientific research institutions by total patent application. Baylor College of Medicine, The Johns Hopkins University, China Pharmaceutical University are dominant in this area. They take 21.30% of the total patent filing.
Baylor College of Medicine
Texas, United States
Patent: 31
The Johns Hopkins University
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 12
Sichuan Sheng, China
Patent: 10
New York, United States
Patent: 9
Guangdong Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 6
Zhejiang Sheng, China
Patent: 6
The Scripps Research Institute
California, United States
Patent: 6
Jiangsu Sheng, China
Patent: 6